PAREXEL International Corp. (PRXL) to Release Quarterly Earnings on Thursday
PAREXEL International Corp. (NASDAQ:PRXL) will announce its earnings results on Thursday, January 30th. Persons interested in registering for the company’s earnings conference call can do so using this link.
Shares of PAREXEL International Corp. (NASDAQ:PRXL) opened at 48.40 on Wednesday. PAREXEL International Corp. has a 1-year low of $31.23 and a 1-year high of $55.02. The stock has a 50-day moving average of $45.09 and a 200-day moving average of $47.23. The company has a market cap of $2.735 billion and a price-to-earnings ratio of 26.23.
A number of analysts have recently weighed in on PRXL shares. Analysts at ISI Group upgraded shares of PAREXEL International Corp. from a “buy” rating to a “strong-buy” rating in a research note to investors on Wednesday, January 22nd. They now have a $56.00 price target on the stock, up previously from $53.00. On a related note, analysts at Thomson Reuters/Verus downgraded shares of PAREXEL International Corp. from a “buy” rating to a “hold” rating in a research note to investors on Monday, January 20th. Finally, analysts at Thomson Reuters/Verus upgraded shares of PAREXEL International Corp. from a “hold” rating to a “buy” rating in a research note to investors on Tuesday, December 24th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating, four have issued a buy rating and two have given a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $51.51.
PAREXEL International Corporation (NASDAQ:PRXL) is a biopharmaceutical services company, providing a range of expertise in clinical research, medical communications, consulting, and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.